Leeder R G, Brien J F, Massey T E
Department of Pharmacology and Toxicology, Queen's University, Kingston, ON, Canada.
Can J Physiol Pharmacol. 1994 Jun;72(6):613-21. doi: 10.1139/y94-087.
Associated with amiodarone (AM) therapy is pneumonitis, which may progress to life-threatening pulmonary fibrosis. Although the etiology of amiodarone-induced pulmonary toxicity (AIPT) is unknown, a role for direct toxicity by oxidative stress has been proposed. We have used a single intratracheal administration of AM (1.8 mg (2.64 mumol)) to male golden Syrian hamsters to investigate the role of oxidative stress in AIPT. The antioxidant capacity of the lung was assessed following AM administration by evaluating glutathione status and antioxidant enzyme activities. The efficacy of treatment with the antioxidant agents butylated hydroxyanisole, diallyl sulfide, and N-acetylcysteine, in attenuation of AM-induced pulmonary fibrosis was also investigated. AM significantly (p < 0.05) increased the ratio of oxidized to total lung glutathione both 30 min (control, 0.93 +/- 0.23%; AM, 2.06 +/- 0.26%) and 120 min (control, 0.90 +/- 0.21%; AM, 3.58 +/- 1.34%) post administration. AM also increased activities of glutathione reductase (by 89%) 3 days post administration, and glutathione peroxidase (by 110 and 45%, respectively) and total superoxide dismutase (by 58 and 35%, respectively) both 3 and 7 days post administration. However, treatment of hamsters with butylated hydroxyanisole (150 mg.kg-1.day-1 s.c.) or diallyl sulfide (200 mg.kg-1.day-1, p.o.) for 3 days prior to AM, or treatment with N-acetylcysteine (10 mg intratracheally) 10 min prior to AM had no effect on pulmonary fibrosis 21 days post treatment, as determined by lung wet weight and hydroxyproline content, and had inconsistent effects on histologically determined disease index.(ABSTRACT TRUNCATED AT 250 WORDS)
胺碘酮(AM)治疗会引发肺炎,且可能进展为危及生命的肺纤维化。尽管胺碘酮诱发肺毒性(AIPT)的病因尚不明确,但已有人提出氧化应激导致直接毒性这一作用机制。我们通过对雄性金黄叙利亚仓鼠单次气管内给予AM(1.8毫克(2.64微摩尔)),来研究氧化应激在AIPT中的作用。给予AM后,通过评估谷胱甘肽状态和抗氧化酶活性来测定肺的抗氧化能力。还研究了抗氧化剂丁基羟基茴香醚、二烯丙基硫醚和N - 乙酰半胱氨酸治疗对减轻AM诱发的肺纤维化的效果。给予AM后30分钟(对照组,0.93±0.23%;AM组,2.06±0.26%)和120分钟(对照组,0.90±0.21%;AM组,3.58±1.34%)时,AM均显著(p<0.05)增加了肺中氧化型谷胱甘肽与总谷胱甘肽的比例。给予AM后3天,AM还使谷胱甘肽还原酶活性增加了89%,给予AM后3天和7天,谷胱甘肽过氧化物酶活性分别增加了110%和45%,总超氧化物歧化酶活性分别增加了58%和35%。然而,在给予AM前3天用丁基羟基茴香醚(150毫克·千克⁻¹·天⁻¹,皮下注射)或二烯丙基硫醚(200毫克·千克⁻¹·天⁻¹,口服)治疗仓鼠,或在给予AM前10分钟气管内给予N - 乙酰半胱氨酸(10毫克),在治疗后21天,根据肺湿重和羟脯氨酸含量测定,对肺纤维化均无影响,且对组织学确定的疾病指数影响不一致。(摘要截断于250字)